Marketing & Strategy
PRIME Awards 2020 call for entries – deadline extended
Marketing & Strategy: The PRIME Awards, the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries with key dates below.
Chair of Judges, Mr David Cousins, returns to oversee and facilitate judging, which this year broadens the review process with a mix of new and returning judges, all highly experienced in their field.
“I’m excited to follow up on the success of 2019 where we had our biggest year ever. To continue to ensure that the highest calibre of work is recognised, in 2020 we have evolved the judging process to a two-stage approach and welcomed new judges,” said Mr Cousins.
In light of the current COVID-19 restrictions, a decision will be made closer to the time regarding the format of the awards ceremony.
“Whilst the current situation is making the future seem uncertain, the PRIME Awards gives us time to reflect on our hard work and ultimately celebrate success – no matter what medium the awards ceremony may be held in” said Mr Cousins.
“Pausing to recognise innovation, collaboration and success in our industry is critical to increasing knowledge and skill as a whole.”
KEY INFORMATION
Entries Open Now and Close
Thursday 25th June
Finalists Announced
Early August
Awards Ceremony
Thursday 24th September
There are 18 categories for teams and individuals within the pharmaceutical and life sciences industry to shine. Full details of the categories and the entry kit can be found at www.primeawards.com.au
Medical
NSW Health to settle ‘largest’ class action
A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]
MoreNews & Trends - Pharmaceuticals
Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap
Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]
MoreNews & Trends - Pharmaceuticals
AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases
Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]
MoreNews & Trends - Pharmaceuticals
PBAC recommendation to reshape prescribing in heart failure
Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]
More